Bing Zhao

532 citations
29 papers · 360 indexed · h-index 10
Topics
Mycobacterium research and diagnosis (6 papers)Tuberculosis Research and Epidemiology (6 papers)Cancer Treatment and Pharmacology (4 papers)
Journals
SHILAP Revista de lepidopterologíaThe Journal of ImmunologyChemical Engineering Journal

In The Last Decade

Bing Zhao

25 papers receiving 357 citations

Peers

Bing Zhao
Comparison fields: 5 of 76
  • Oncology 168
  • Molecular Biology 164
  • Pulmonary and Respiratory Medicine 64
  • Infectious Diseases 49
  • Organic Chemistry 40
Replace Megumi Murakami with:
Megumi Murakami United States
Csilla Hegedüs Hungary
Belén Valenzuela Spain
David M. Gustin United States
Ralf Häfer Germany
Yujin Wang China
Xiaoping Chen China
Yuehong Wang China
Lenka Gibalová Slovakia
Andy Chao Hsuan Lee United States
Bing Zhao relative to Megumi Murakami United States Megumi Murakami's profile →
Citations per field
00.5×2.8×
Megumi Murakami · 1×
Citations per year

Countries citing papers authored by Bing Zhao

Since Specialization
Citations

This map shows the geographic impact of Bing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Zhao more than expected).

Fields of papers citing papers by Bing Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Zhao. The network helps show where Bing Zhao may publish in the future.

Co-authorship network of co-authors of Bing Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Zhao. A scholar is included among the top collaborators of Bing Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Zhao. Bing Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 3
4 0
5 1
6 12
7 4
8 0
9 39
10 1
11 22
12 5
13 5
14 9
15 1
16 9
17 45
18 0
19 47
20 14

About Bing Zhao

Bing Zhao is a scholar working on Infectious Diseases, Oncology and Toxicology, having authored 29 papers that have together received 360 indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (6 papers), Tuberculosis Research and Epidemiology (6 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Oncology (168 citations), Infectious Diseases (49 citations) and Molecular Biology (164 citations). Bing Zhao has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Jinbing Sun, Juan Ye, Peng Cao, Zhe‐Sheng Chen, Xinhui Zhang, Hong‐Min Liu, Liying Ma, Jun Li, Xuejiao Gao and Xi Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026